forty four Moreover, anergic cells normally keep the next susceptibility to apoptosis unless anti-apoptotic proteins such as BCL2 are overexpressed, as is the situation for CLL cells.45 In truth, most key therapeutic improvements occurring in the final decade are related to the inhibition of BCR and